News
Recombinant extracellular vesicles
Engineering of CD81 on extracellular vesicles to target specific cell surface proteins.
Evercyte is hiring!
Evercyte is looking for dedicated team players to support our bioassay development group!
MDimune and Evercyte form partnership for developing tumor-targeting EVs
MDimune and Evercyte form partnership for developing tumor-targeting EVs April 1, 2021,
Mass production of spheroids from ASC/TERT1
Mass production of spheroids from ASC/TERT1 standardized
Lecture on 3Rs
Lecture on 3Rs (replacement-reduction-refinement) of animal experiments New lecture on